Relmada Therapeutics, Inc.

News

Latest Press Releases, Articles & Media Resources

Press Releases

July 13, 2020
Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select Market®

NEW YORK, July 13, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, announced that effective as of market open on July 14, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker… Read More »

More Press Releases